Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.

AIM To explore the effect and significance of inhibitor of growth 1 (ING1) gene in carcinogenesis and progression of human sporadic colorectal cancer. METHODS mRNA expression, mutation, and loss of heterozygosity (LOH) of ING1 gene in 35 specimens of sporadic colorectal cancer tissues and the matched normal mucous membrane tissues were detected by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), PCR-single strain conformation polymorphism (PCR-SSCP) and PCR-simple sequence length polymorphism (PCR-SSLP) using microsatellite markers, respectively. RESULTS The average ratios of light intensities of p33(ING1b) and p47(ING1a) mRNA expression in the cancerous tissues were significantly lower than those in normal tissues. The difference between the two mRNA splices was not significant in the matched tissues. In addition, the ratios of light intensities of p33(ING1b) and p47(ING1a) mRNA expression in the cancerous tissues of Dukes' stages C and D were significantly lower than those in cancerous tissues of Dukes' stages A and B. However, no mutation of ING1 gene was detected in all 35 cases; only 4 cases of LOH (11.4%) were found. CONCLUSION p33(ING1b) and p47(ING1a) mRNA expressions are closely related with the carcinogenesis and progression of human sporadic colorectal cancer. No mutation of ING1 gene is found, and there are only few LOH in sporadic colorectal cancers. These might not be the main reasons for the down regulation of ING1 expression. Its low expression may happen in transcription or post-transcription.

[1]  Ming-hua Zhu,et al.  Genetic alterations and reduced expression of tumor suppressor p33(ING1b) in human exocrine pancreatic carcinoma. , 2004, World journal of gastroenterology.

[2]  A. Nakagawara,et al.  Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas. , 2004, Oncology reports.

[3]  S. Sumitomo,et al.  Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  C. Harris,et al.  ING1 represses transcription by direct DNA binding and through effects on p53. , 2003, Cancer research.

[5]  Wentian Li,et al.  Copyright © American Society for Investigative Pathology Gene Discovery in Bladder Cancer Progression using cDNA Microarrays , 2022 .

[6]  J. Lunec,et al.  Downregulation of nuclear expression of the p33ING1b inhibitor of growth protein in invasive carcinoma of the breast , 2003, Journal of clinical pathology.

[7]  M. Martinka,et al.  Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma. , 2003, International journal of oncology.

[8]  Li Dong Wang,et al.  ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction. , 2003, Cancer letters.

[9]  K. Riabowol,et al.  Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells. , 2003, Anticancer research.

[10]  Sikuan Zheng,et al.  [p33(ING1) gene expression and mutation in stomach cancer tissues and precarcinomatous tissues]. , 2003, Zhonghua yi xue za zhi.

[11]  Minghua Zhu,et al.  [Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma]. , 2002, Zhonghua yi xue za zhi.

[12]  Lai See Po,et al.  The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. , 2002, Cancer research.

[13]  F. Boisvert,et al.  Human ING1 Proteins Differentially Regulate Histone Acetylation* , 2002, The Journal of Biological Chemistry.

[14]  C. Lynas,et al.  Relative levels of alternative transcripts of the ING1 gene and lack of mutations of p33/ING1 in haematological malignancies. , 2002, Leukemia research.

[15]  A. Morishita,et al.  Expression of p33 ING1 in Hepatocellular Carcinoma: Relationships to Tumour Differentiation and Cyclin E Kinase Activity , 2002, Scandinavian journal of gastroenterology.

[16]  N. Matsubara,et al.  Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. , 2001, Cancer research.

[17]  N. Tsuchida,et al.  Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. , 2001, Oral oncology.

[18]  S. Nishioka,et al.  Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. , 2000, Cancer research.

[19]  D. Sidransky,et al.  Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions , 2000, Genes, chromosomes & cancer.

[20]  E. Tokunaga,et al.  Reduced expression of p33ING1 and the relationship with p53 expression in human gastric cancer , 1999 .

[21]  T. Furukawa,et al.  Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. , 1999, Cancer research.

[22]  H. Koeffler,et al.  Decreased expression of p33ING1 mRNA in lymphoid malignancies , 1999, American journal of hematology.

[23]  P. Watson,et al.  Suppression of ING1 expression in sporadic breast cancer , 1999, Oncogene.

[24]  P. Guillou,et al.  The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas. , 1999, European journal of cancer.

[25]  E. Tokunaga,et al.  Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. , 1999, Cancer letters.

[26]  I. Garkavtsev,et al.  The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control , 1998, Nature.

[27]  M. Zeremski,et al.  Localization of the candidate tumor suppressor geneING1 to human chromosome 13q34 , 1997, Somatic cell and molecular genetics.

[28]  I. Garkavtsev,et al.  Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor , 1997, Molecular and cellular biology.

[29]  I. Garkavtsev,et al.  A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. , 1997, Cancer research.

[30]  D. Demetrick,et al.  Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). , 1997, Cytogenetics and cell genetics.

[31]  I. Garkavtsev,et al.  Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation , 1996, Nature Genetics.

[32]  B J Bassam,et al.  Fast and sensitive silver staining of DNA in polyacrylamide gels. , 1991, Analytical biochemistry.